Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma (Q45136856)

9 December 2017

title

Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma (English)

1 reference

9 December 2017

P Kristensen

1

1 reference

9 December 2017

C Pyke

2

1 reference

9 December 2017

L R Lund

3

1 reference

9 December 2017

P A Andreasen

4

1 reference

9 December 2017

K Danø

5

1 reference

9 December 2017

publication date

1 January 1990

1 reference

9 December 2017

1 reference

9 December 2017

volume

93

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

559-566

1 reference

Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00272198

Plasminogen activator from cells transformed by an oncogenic virus. Inhibitors of the activation reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00272198

Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00272198

Cell-associated plasminogen activation: regulation and physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00272198

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse

21 January 2018

1 reference

12 December 2020

A tetrazolium method for non-specific alkaline phosphatase

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

1 reference

12 December 2020

Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland

1 reference

12 December 2020

Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family

1 reference

12 December 2020

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

1 reference

12 December 2020

Human endothelial cells contain one type of plasminogen activator

1 reference

12 December 2020

A study of proteases and protease-inhibitor complexes in biological fluids

1 reference

12 December 2020

Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions

1 reference

12 December 2020

Changes in malignant phenotype of a human carcinoma conditioned by growth environment

1 reference

12 December 2020

Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.

1 reference

12 December 2020

Reverse fibrin autography: a method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate--polyacrylamide gel electrophoresis.

1 reference

12 December 2020

Tissue-type plasminogen activator in rat adrenal medulla

1 reference

12 December 2020

The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene

1 reference

12 December 2020

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

1 reference

12 December 2020

The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related

1 reference

12 December 2020

Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass

1 reference

12 December 2020

Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta

1 reference

12 December 2020

Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells

1 reference

12 December 2020

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

12 December 2020

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

12 December 2020

Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme

1 reference

12 December 2020

Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts

1 reference

12 December 2020

The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases

1 reference

12 December 2020

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

1 reference

12 December 2020

Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots

1 reference

12 December 2020

Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy

1 reference

12 December 2020

Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification

1 reference

12 December 2020

Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes

1 reference

12 December 2020

Tissue-type plasminogen activator in somatostatin cells of rat pancreas and hypothalamus

1 reference

12 December 2020

Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma

1 reference

12 December 2020

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

1 reference

12 December 2020

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1 reference

12 December 2020

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

1 reference

12 December 2020

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

1 reference

12 December 2020

Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin

1 reference

12 December 2020

Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors

1 reference

12 December 2020

The clonal evolution of tumor cell populations

1 reference

12 December 2020

Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin

1 reference

12 December 2020

Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00272198

1 reference

9 December 2017

1 reference